Momnext Pharma Private Limited
Founded in 2020 and headquartered in Uttar Pradesh, India.
2020 | Ghaziabad, Uttar Pradesh (India) | Active
Momnext Pharma Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 4 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth 532.55%
- Profit Growth 74.28%
- Ebitda -18.86%
- Net Worth -503.82%
- Total Assets 109.50%
About Momnext Pharma
Momnext Pharma Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 August 2020 (Four years and six months 17 days old ). Its registered office is in Ghaziabad, Uttar Pradesh, India.
The Company is engaged in the Trading Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Ashish Ranjan and Sweta Bharti serve as directors at the Company.
Company Details
- Location
Ghaziabad, Uttar Pradesh, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U51909UP2020PTC132531
- Company No.
132531
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2020
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Trading
Other Industry
Who are the key members and board of directors at Momnext Pharma?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashish Ranjan  | Director | 11-Aug-2020 | Current |
| Sweta Bharti | Director | 11-Aug-2020 | Current |
Financial Performance of Momnext Pharma.
Momnext Pharma Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 532.55% increase. The company also saw a substantial improvement in profitability, with a 74.28% increase in profit. The company's net worth observed a substantial decline by a decrease of 503.82%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Momnext Pharma?
Unlock access to Momnext Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Momnext Pharma?
Unlock and access historical data on people associated with Momnext Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Momnext Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Momnext Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.